0001437749-21-000609.txt : 20210211 0001437749-21-000609.hdr.sgml : 20210211 20210113085231 ACCESSION NUMBER: 0001437749-21-000609 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20210113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIVEVE MEDICAL, INC. CENTRAL INDEX KEY: 0000879682 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043153858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH STREET 2: BUILDING B, SUITE 250 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 4085301900 MAIL ADDRESS: STREET 1: 345 INVERNESS DRIVE SOUTH STREET 2: BUILDING B, SUITE 250 CITY: ENGLEWOOD STATE: CO ZIP: 80112 FORMER COMPANY: FORMER CONFORMED NAME: PLC SYSTEMS INC DATE OF NAME CHANGE: 19930328 CORRESP 1 filename1.htm vive20210112_corresp.htm

 

January 13, 2021

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street N.E.

Washington, D.C.  20549

Attn: Alan Campbell

 

 

RE:

Viveve Medical Inc. (the “Registrant”) – Request for Acceleration
Registration Statement on Form S-1
   

File No. 333-251517

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), A.G.P./Alliance Global Partners, as representative of the several underwriters, hereby join in the request of the Registrant for the acceleration of the effective date of the above-referenced Registration Statement, so that it will become effective at 5:00 p.m., Eastern Time, on Wednesday, January 13, 2021, or as soon thereafter as reasonably practicable.

 

We hereby authorize each of Aron Izower and Wendy Grasso of Reed Smith LLP, attorneys for the underwriters, to orally modify or withdraw this request for acceleration.

 

Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the securities, as many copies of the preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

 

The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.

 

  Very truly yours,  
       
  A.G.P./ALLIANCE GLOBAL PARTNERS  
       
       
  By: /s/ Tom Higgins  
  Name: Tom Higgins  
  Title: Managing Director